Changes in Beneficial Ownership · 4
Elutia Inc.
ELUTNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4-09142026_050909.xml
Filing details
- Report period
- 2026-09-10
- Issuer
- ELUTIA INC.
- Issuer CIK
- 0001708527
- Trading symbol
- ELUT
Reporting owner 1
- Name
- Williams Michelle LeRoux
- Reporting owner CIK
- 0001398249
- Relationship
- Officer
- Officer title
- CHIEF SCIENTIFIC OFFICER
- Address
- C/O ELUTIA INC., 20 FIRSTFIELD ROAD, GAITHERSBURG, MD, 20878
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | 2026-09-10 | M · Form 4 | 12,500[F1] | A | [F2] | 130,552 | D |
| Class A Common Stock | 2026-09-10 | F · Form 4 | 4,269[F3] | D | 0.80 | 126,283 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- F · Form 4
- Securities delivered or withheld for exercise price or tax liability under Rule 16b-3
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units | [F2] | 2026-09-10 | M · Form 4 | 12,500 | D | 0 | [F4] | [F4] | Class A Common Stock | 12,500 | 12,500 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
- F1
- Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.↩ 1
- F2
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.↩ 1↩ 2
- F3
- Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.↩ 1
- F4
- On January 31, 2024, the Reporting Person was granted 150,000 restricted stock units. Restricted stock units as to 1/6 vest on June 10, 2024, and as to 1/12 vest quarterly on each of the following dates: September 10, 2024, December 10, 2024, March 10, 2025, June 10, 2025, September 10, 2025, December 10, 2025, March 10, 2026, June 10, 2026, September 10, 2026, and December 10, 2026.↩ 1↩ 2
Signature 1
- Signed
- /s/ Jeffrey Hamet, Attorney-in-Fact for Michelle LeRoux Williams
- Date
- 2026-09-14
Company context
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www. Elutia.com.